ArticleScientific reports2019

Targeting CLDN18.2 by CD3 Bispecific and ADC Modalities for the Treatments of Gastric and Pancreatic Cancer.

Guoyun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.